.jpeg?crop=yes&w=1665&h=876&a=0,71&itok=bljecf_w "obesity_scan_icons"){kind=icon}
ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle...
Strategies for adapting and achieving optimal biosimilar market access
Download the whitepaperBuilding a comparative evidence base using network meta-analysis:
Methods, implementation and reporting
Read the whitepaperDemystifying the SLR: “S” stands for systematic
A structured approach to evidence-based decision-making
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
ICON Cares program
Expresses our passion and achievements around environmental, social and governance (ESG) efforts.
Webinars
Enhancing clinical trials in obesity by integrating COAs and DHTs
7 October 2025. Register now.
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
22 October 2025. Register now.
From Fragmented to Fluid: A Deep Dive into Claims Data Innovation
Watch the recording.
